Form 4: Director Charles R. Romp Receives Celcuity Equity Grant

Director Charles R. Romp acquired 1,530 restricted stock units in Celcuity Inc. as part of a standard equity compensation grant.

Summary

• Director Charles R. Romp was granted 1,530 restricted stock units (RSUs) of Celcuity Inc. common stock.
• The transaction occurred on June 5, 2026.
• The RSUs were granted at a price of $0 per share as part of equity compensation.
• Following this transaction, the director's total beneficial ownership of common stock increased to 1,745 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting of the restricted stock units is contingent upon the 2027 annual meeting of stockholders or April 30, 2027, whichever occurs first.

Future Outlook

The restricted stock units are scheduled to vest on the earlier of the 2027 annual meeting of stockholders or April 30, 2027.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practices designed to align board incentives with long-term shareholder value in the biotechnology sector.

Comparison to Industry Standards

• The grant of restricted stock units to directors is consistent with standard compensation practices for small-cap biotechnology companies.
• The vesting schedule tied to annual meetings is a common industry practice for board members.

Stakeholder Impact

• Minor dilution impact on existing shareholders due to the issuance of new equity units.

Next Steps

• Vesting of restricted stock units by April 30, 2027, or the 2027 annual meeting.

Key Dates

Keywords

Celcuity, CELC, Form 4, Insider Trading, Director Compensation, Restricted Stock Units